About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in Salt Lake City | 7,997 Studies Near You | Clareo Health

Clinical Trials LocationsSalt Lake City

Clinical Trials in Salt Lake City

Discover 7,997 clinical trials near Salt Lake City, Utah. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 1881-1900 of 7,997 trials

Active Not RecruitingPhase 1< 1 mile

QTX3046 in Patients With KRAS G12D Mutations

NCT06428500

Phase 1 study to determine the safety and tolerability of QTX3046 as a single agent or in combination with cetuximab.

Advanced Solid Tumor

Quanta Therapeutics240 participantsStarted May 2024

Grand Rapids, Michigan, United States • Durham, North Carolina, United States • Houston, Texas, United States +2 more locations

COMPLETEDPhase 3< 1 mile

Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis

NCT04028492

To investigate the safety and efficacy of tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.

Idiopathic GastroparesisDiabetic GastroparesisGastroparesis

Vanda Pharmaceuticals992 participantsStarted Aug 2019

Birmingham, Alabama, United States • Peoria, Arizona, United States • Little Rock, Arkansas, United States +33 more locations

Find Trials by Condition in Salt Lake City

Breast Cancerin Salt Lake City Lung Cancerin Salt Lake City Prostate Cancerin Salt Lake City Colorectal Cancerin Salt Lake City Melanomain Salt Lake City Leukemiain Salt Lake City Lymphomain Salt Lake City Pancreatic Cancerin Salt Lake City Ovarian Cancerin Salt Lake City Brain Cancerin Salt Lake City

Data from ClinicalTrials.govTerms

Active Not Recruiting< 1 mile

PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort

NCT02407431

The purpose of the PaTH Network IPF Clinician-Patient Partnership Cohort is to use clinical data from electronic health records (EHR) and patient reported outcomes (PRO) to answer questions of clinical importance to patients with Idiopathic Pulmonary Fibrosis, providers, and other stakeholders.

Idiopathic Pulmonary Fibrosis

University of Pittsburgh1,000 participantsStarted Mar 2015

Baltimore, Maryland, United States • Hershey, Pennsylvania, United States • Philadelphia, Pennsylvania, United States +2 more locations

COMPLETEDPhase 17.5 miles

Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies

NCT05391022

Phase 1 2-part study to evaluate the effect of food on pharmacokinetics of pelabresib (CPI-0610) and the effect of pelabresib on QTc in patients with advanced malignancies

Advanced MalignanciesSolid TumorHematological Malignancy

Constellation Pharmaceuticals35 participantsStarted Jul 2021

Canton, Ohio, United States • Gettysburg, Pennsylvania, United States • West Valley City, Utah, United States +7 more locations

TERMINATEDPhase 211 miles

Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection

NCT06585150

The goal of this clinical study is to learn more about the study drug, obeldesivir (ODV; GS-5245), and how safe and effective it is in treating nonhospitalized adults with acute respiratory syncytial virus (RSV) infection. The researchers want to see if obeldesivir can help participants' symptoms get better faster. The primary objectives of this study are to evaluate the efficacy of ODV in reducing the duration of symptoms and to evaluate the safety and tolerability of ODV in nonhospitalized adult participants with acute RSV infection.

Gilead Sciences150 participantsStarted Oct 2024

Birmingham, Alabama, United States • Cullman, Alabama, United States • Guntersville, Alabama, United States +118 more locations

RECRUITINGPhase 2212 miles

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

NCT05966493

This study is to evaluate the safety and efficacy of NEXAGON® (lufepirsen ophthalmic gel) (NEXAGON) in subjects with persistent corneal epithelial defects (PCED). The objectives of the study are to evaluate the safety and efficacy of NEXAGON in this population.

Persistent Corneal Epithelial Defect

Glaukos Corporation84 participantsStarted Aug 2023

Dothan, Alabama, United States • Petaluma, California, United States • Torrance, California, United States +25 more locations

COMPLETEDPhase 3362 miles

A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

NCT02684006

This is a phase 3 randomized trial evaluating the anti-tumor activity and safety of avelumab in combination with axitinib and of sunitinib monotherapy, administered as first-line treatment, in patients with advanced renal cell carcinoma

Renal Cell Cancer

Pfizer886 participantsStarted Mar 2016

Daphne, Alabama, United States • Mobile, Alabama, United States • Mobile, Alabama, United States +267 more locations

COMPLETED362 miles

Development and Validation of Harbinger Health Test for Early Cancer Detection

NCT05435066

This is a prospective, multi-center, observational study with a collection of biospecimens and clinical data from approximately 10,000 participants from up to 125 clinical network sites and locations in the United States. The objective of this study is to collect blood samples, tissue samples, and associated clinical data from participants with a variety of solid tumor and hematologic cancers and non-cancer participants for testing and the development of a screening test for early cancer detection.

Harbinger Health8,038 participantsStarted Jun 2022

Daphne, Alabama, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +125 more locations

COMPLETEDPhase 2362 miles

A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia

NCT05443724

The primary purpose of this study is to assess the long-term safety and tolerability of oral emraclidine in adult participants with schizophrenia.

AbbVie700 participantsStarted Sep 2022

Phoenix, Arizona, United States • Bryant, Arkansas, United States • Little Rock, Arkansas, United States +82 more locations

RECRUITINGNA371 miles

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

NCT05237258

This research study is evaluating whether primary palliative care is an alternative strategy to specialty palliative care for improving quality of life, symptoms, mood, coping, and end of life outcomes in patients with acute myeloid leukemia (AML).

Relapsed Adult AMLPrimary Refractory Acute Myeloid LeukemiaHigh Risk Acute Myeloid Leukemia

Massachusetts General Hospital2,300 participantsStarted Jun 2022

Birmingham, Alabama, United States • Stanford, California, United States • Denver, Colorado, United States +17 more locations

COMPLETEDPhase 3379 miles

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

NCT04026412

The primary purpose of the study is to compare the effectiveness of nivolumab plus concurrent chemoradiotherapy (CCRT) followed by nivolumab plus ipilimumab vs CCRT followed by durvalumab in participants with untreated Locally Advanced Non-small Cell Lung Cancer (LA NSCLC).

Non-Small Cell Lung Cancer (NSCLC)

Bristol-Myers Squibb925 participantsStarted Oct 2019

La Jolla, California, United States • San Francisco, California, United States • San Francisco, California, United States +180 more locations

TERMINATEDPhase 2505 miles

Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

NCT04864392

The study will determine the optimal dosing regimen of LNA043 in patients with knee osteoarthritis (OA).

Novartis Pharmaceuticals582 participantsStarted May 2021

Phoenix, Arizona, United States • Tucson, Arizona, United States • La Mesa, California, United States +73 more locations

RECRUITINGNA508 miles

TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD

NCT06815302

The goals of this clinical trial are to 1) learn how two different rehabilitation interventions for PD can reduce Freezing of Gait (FOG) in people with Parkinson's disease, as assessed by patients, clinicians, and wearable sensors, and 2) to explore whether two different rehabilitation intervention can reduce FOG and improve daily life mobility in people with FOG sufficiently to justify a clinical trial. Participants will: * Be randomly assigned to one of two intervention groups (turning-focused agility exercise or strength-based exercise) * Have one-on-one training sessions three times per week for 6 weeks * Perform in-lab assessments before beginning and after completing the study intervention * Use wearable mobility sensors during daily life to measure their walking and balance

Parkinson DiseaseFreezing of Gait Symptoms in Parkinson Disease

Oregon Health and Science University60 participantsStarted Jun 2025

Tempe, Arizona, United States • Portland, Oregon, United States • Bauru, São Paulo, Brazil

RECRUITINGNA540 miles

Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference

NCT07089615

Note: This is the same study protocol as NCT04607746 with slight changes to how the videos will be read and a 2nd generation capsule is being studied. The purpose of this study is to evaluate the safety and effectiveness of CapsoCam® Colon (CV-3) endoscope system for the detection of colonic polyps and to show that AI-based CADe improves the polyp-detection accuracy and efficiency of capsule video readers. It will use colonoscopy results as a reference. The participant will: 1. prep for and swallow a study capsule and then 2. prep for and undergo a colonoscopy either the following day or 3-6 weeks later

Capso Vision, Inc.330 participantsStarted Jun 2025

Chula Vista, California, United States • Lancaster, California, United States • Orange, California, United States +8 more locations

Active Not RecruitingPhase 2575 miles

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

NCT01594723

The primary purpose of this study is to measure the response rate in participants with the myeloproliferative neoplasms (MPNs), polycythemia vera (PV), essential thrombocythemia (ET), or myelofibrosis (MF) when treated with LY2784544, including those who have demonstrated an intolerance to, failure of primary response to, or have demonstrated disease progression while on ruxolitinib.

Neoplasms, Hematologic

Eli Lilly and Company110 participantsStarted May 2012

Rogers, Arkansas, United States • Burbank, California, United States • Norwalk, Connecticut, United States +36 more locations

Active Not Recruiting577 miles

A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS

NCT06076499

Multi-center post-market, observational study to assess the long-term effectiveness and safety of the NTX100 TOMAC System for patients with Restless Legs Syndrome.

Restless Legs Syndrome

Noctrix Health, Inc.325 participantsStarted Nov 2023

Downey, California, United States • San Ramon, California, United States • Newton, Massachusetts, United States +3 more locations

Active Not RecruitingPhase 2586 miles

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

NCT06537414

The study is intended to evaluate the efficacy and safety of 2 different doses of DAP/TOM followed by bepirovirsen in participants living with CHB on standard of care nucleos(t)ide analogue (NA) therapy. The study also aims to identify an optimal dose of DAP/TOM for sequenced therapy with bepirovirsen for further clinical development and to assess the contribution of DAP/TOM to the sequential regimen.

Chronic Hepatitis B Virus InfectionHepatitis B

GlaxoSmithKline283 participantsStarted Nov 2024

San Francisco, California, United States • San Jose, California, United States • Minneapolis, Minnesota, United States +78 more locations

COMPLETEDPhase 4595 miles

Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)

NCT03909165

This study will evaluate the efficacy, safety, and pharmacokinetics (PK) of sugammadex (MK-8616) for reversal of both moderate and deep neuromuscular blockade (NMB) in pediatric participants aged birth to \<2 years. The primary hypothesis of this study is that sugammadex is superior to neostigmine in reversing moderate NMB as measured by time to neuromuscular recovery.

Neuromuscular Blockade

Merck Sharp & Dohme LLC145 participantsStarted Jul 2019

Palo Alto, California, United States • Miami, Florida, United States • Oklahoma City, Oklahoma, United States +36 more locations

RECRUITING595 miles

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

NCT05750498

The Autoimmune Liver disease Network for Kids (A-LiNK) is a multi-institutional group with the mission to deliver the best care to kids with pediatric autoimmune liver disease (AILD). This study will establish a shared clinical registry and a learning health network for the participating sites focusing on collecting and transmitting clinical measurement data, information about processes, and participation in an improvement collaborative. Pediatric Autoimmune Hepatitis (AIH) and Primary Sclerosing Cholangitis (PSC), represent a spectrum of AILD which present unique diagnostic and therapeutic challenges.A lack of accepted guidelines for disease monitoring or symptom management results in wide treatment variation with liver transplants indicated in refractory, progressive disease. The aims of A-LiNK are to: 1.) Create a learning health network focused on patient-centered outcomes research characterized by transparent sharing among centers, common priorities, and feasible plans for implementing new practices; 2) shift from traditional investigator-driven study to a patient and family-centered approach, and 3.) improve clinical outcomes and quality of life for pediatric AILD patients.

Autoimmune HepatitisPrimary Sclerosing Cholangitis

Children's Hospital Medical Center, Cincinnati800 participantsStarted Apr 2022

Palo Alto, California, United States • Indianapolis, Indiana, United States • St Louis, Missouri, United States +5 more locations

TERMINATED622 miles

A Long-term Follow-up Study of Patients Who Received VOR33

NCT05309733

VOR33 long-term follow-up (LTFU) study

Leukemia, Myeloid, Acute

Vor Biopharma10 participantsStarted Apr 2022

La Jolla, California, United States • Miami, Florida, United States • Bethesda, Maryland, United States +8 more locations

PreviousPage 95 of 400Next

Diabetes

in Salt Lake City

Heart Diseasein Salt Lake City